Genetics and hypogonadotrophic hypogonadism

被引:3
|
作者
Hay, C [1 ]
Wu, F [1 ]
机构
[1] Manchester Royal Infirm, Dept Endocrinol, Manchester M13 9WL, Lancs, England
关键词
D O I
10.1097/00001703-200206000-00010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Hypothalamic pulsatile gonadotrophin-releasing hormone secretion, stimulating pituitary gonadotrophin secretion, is essential for adult reproductive function. This neuroendocrine drive to the reproductive axis is critically dependent on a sequence of developmental events in utero. During early foetal life, gonadotrophin-releasing hormone neurones migrate from the nasal placode to the medial basal hypothalamus where gonadotrophin-releasing hormone can be transported down portal vessels to the anterior pituitary. Gonadotrophin-releasing hormone secretion is active fleetingly neonatally but soon becomes quiescent throughout childhood. At the time of puberty activation of gonadotrophin-releasing hormone secretion reawakens the hyphothalamic pictuitary-gonadal axis and secondary sexual maturation is triggered. Any disruption in gonadotrophin-releasing hormone secretion will result in hypogonadotrophic hypogonadism. The clinical manifestations of this become apparent with secondary sexual maturation. Genetic mutations have been identified in a minority of cases. These include Kallmann syndrome, adrenal hypoplasia congenital, gonadotropin-releasing hormone receptor and luteinizing hormone or follicle-stimulating hormone beta-subunit gene mutations. The importance of these discoveries is important not only in relation to the conditions that result, but also for our better understanding of normal reproductive function.
引用
收藏
页码:303 / 308
页数:6
相关论文
共 50 条
  • [41] MALE HYPOGONADOTROPHIC HYPOGONADISM TREATED WITH HUMAN CHORIONIC GONADOTROPHIN
    FRASER, TR
    JOPLIN, GF
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1970, 63 (06): : 575 - &
  • [42] Increased prevalence of hypogonadotrophic hypogonadism in type 2 diabetes
    Dhindsa, S
    Prabhakar, S
    Chaudhuri, A
    Dandona, P
    DIABETES, 2004, 53 : A176 - A176
  • [43] mRNA expression of genes responsible for female hypogonadotrophic hypogonadism
    Loktionova, Anna
    Eneva, Natela
    Khusniyarova, Karina
    Nefedova, Lidia
    Kim, Alexander
    Dreval, Alexander
    Ilovayskaya, Irena
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 48 - 48
  • [44] Voice changes after androgen therapy for hypogonadotrophic hypogonadism
    Akcam, T
    Bolu, E
    Merati, AL
    Durmus, C
    Gerek, M
    Ozkaptan, Y
    LARYNGOSCOPE, 2004, 114 (09): : 1587 - 1591
  • [45] THE ASSESSMENT OF HORMONE REPLACEMENT THERAPY SUCCESS DUE TO HYPOGONADOTROPHIC HYPOGONADISM
    Salabas, E.
    Boyuk, A.
    Bese, C.
    Kadioglu, a
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 : 87 - 87
  • [46] Successful fertility treatment with gonadotrophin therapy for male hypogonadotrophic hypogonadism
    Rajkanna, J.
    Tariq, S.
    Oyibo, S. O.
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2016,
  • [47] Disrupted Kisspeptin Signaling in GnRH Neurons Leads to Hypogonadotrophic Hypogonadism
    Novaira, Horacio J.
    Sonko, Momodou L.
    Hoffman, Gloria
    Koo, Yongbum
    Ko, Chemyong
    Wolfe, Andrew
    Radovick, Sally
    MOLECULAR ENDOCRINOLOGY, 2014, 28 (02) : 225 - 238
  • [48] Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism
    Rafif Farhat
    Fatma Al-zidjali
    Ali S. Alzahrani
    Pituitary, 2010, 13 : 105 - 110
  • [49] Reproductive outcomes in women with hypogonadotrophic hypogonadism, a case series study
    Abdelaal, Ahmed Elsayed
    Behery, Mohamed Atef
    Abdelkawi, Ahmed Farouk
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2021, 26 (01)
  • [50] Evaluation of vascular reactivity of young male hypogonadotrophic hypogonadism patients
    Ferhat Deniz
    Necip Ermiş
    Alper Kepez
    Barış Türk
    Murat Akkoyunlu
    Batuhan Kara
    Mustafa Kutlu
    The International Journal of Cardiovascular Imaging, 2010, 26 : 35 - 40